Publikationsdatum:
2016-03-16
Beschreibung:
We read with great interest the article by Davare et al. (1) on structural insight of ROS1 tyrosine kinase inhibitors. Non-small cell lung cancer (NSCLC) is no longer a single disease but a collection of genetically heterogeneous tumors with different therapeutic options [e.g., aberrations in EGFR, BRAF, HER2/Neu, RET, anaplastic...
Schlagwort(e):
Letters
Print ISSN:
0027-8424
Digitale ISSN:
1091-6490
Thema:
Biologie
,
Medizin
,
Allgemeine Naturwissenschaft
Permalink